Target of rapamycin inhibitors (TOR‐I) vs calcineurin inhibitors (CNI): main outcomes
Graft loss censored for death · primary immunosuppression in kidney transplant recipients
Target of rapamycin inhibitors (TOR‐I) showed no clear difference in graft loss censored for death compared with calcineurin inhibitors (CNI): main outcomes (moderate certainty).
1 finding from 1 review
- Target of rapamycin inhibitors (TOR‐I; sirolimus and everolimus) for primary immunosuppression in kidney transplant… 2019 · Cochrane Headline outcomes onlyRR 1.32 [0.96, 1.81]14 studies · 3277 participantsModerate